We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Incyte Announces Global License Agreement with Jiangsu Hengrui Medicine for SHR-1210

News   Sep 07, 2015

 
Incyte Announces Global License Agreement with Jiangsu Hengrui Medicine for SHR-1210
 
 
Advertisement
 

RELATED ARTICLES

Bacterial Enzymes Hijacked To Create Complex Molecules Usually Made by Plants

News

Chemists at Scripps Research have efficiently created three families of complex, oxygen-containing molecules that are normally obtainable only from plants.

READ MORE

Russia’s COVID-19 Vaccine “Approved" Despite No Phase III Data

News

The scientific community has been left somewhat perplexed after Russian President Vladamir Putin announced that Russian authorities have approved the world's first COVID-19 vaccine.

READ MORE

Recreating Nature: Chemists Create Synthetic Version of Natural Anti-Cancer Agent

News

Scripps Research chemists Hans Renata, PhD, and Alexander Adibekian, PhD, have discovered a way to efficiently create a synthetic version of a valuable natural compound called cepafungin I, which has shown promise as an anti-cancer agent.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE